Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.980
-0.020 (-1.00%)
At close: Apr 10, 2026, 4:00 PM EDT
1.950
-0.030 (-1.52%)
Pre-market: Apr 13, 2026, 6:03 AM EDT
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $24.38 million as of April 13, 2026. Its market cap has decreased by -46.86% in one year.
Market Cap
24.38M
Enterprise Value
24.65M
1-Year Change
-46.86%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $24.38M, a decrease of -80.51%. That is a compound annual growth rate of -55.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 24.38M | 19.52% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 26.64M |
| Outlook Therapeutics | 26.05M |
| Neuphoria Therapeutics | 25.77M |
| Boundless Bio | 25.32M |
| NeuroSense Therapeutics | 24.74M |
| Exicure | 24.07M |
| Skye Bioscience | 24.03M |
| Tevogen Bio Holdings | 23.86M |